Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nutritional Interventions for NAFLD in HIV
NCT00152815Phase 2Terminated
- Start
- Oct 2003
- Primary completion
- Dec 2010
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2, randomised trial of vitamin e in non-alcoholic fatty liver disease (NAFLD) (2 arms). Primary endpoint: Change in grading of inflammation assessed by liver biopsy at 12 months. Started Oct 2003; status: terminated.
02
Drugs
vitamin e
03
Conditions
non-alcoholic fatty liver disease (NAFLD)
Beyond the preview
Go deeper on NCT00152815.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00152815.